Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.
| Autor: | Nissen NI, Hansen HH, Pedersen H, Stroyer I, Dombernowsky P, Hessellund M |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cancer chemotherapy reports [Cancer Chemother Rep] 1975 Sep-Oct; Vol. 59 (5), pp. 1027-9. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|